Our results demonstrate that RBM3 expression was unrelated to p53 expression in all esophageal cancer samples (p = 0.1098), as well as the subset of EACs (p = 0.8339) and ESCCs (p = 0.1466). This evidence concerns the gene TP53 and esophageal cancer.